Ligand Pharmaceuticals | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
Amgen USD 8.03B 782M 2025-06
Arrowhead Research USD 129.79M 55.92M 2025-06
Baxter International USD 2.29B 530M 2025-03
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Eli Lilly USD 3.38B 282.6M 2025-06
Gilead Sciences USD 5.14B 2.78B 2025-06
GlaxoSmithKline GBP 3.6B 865M 2025-06
Glaxosmithkline GBP 3.87B 678M 2024-12
Insmed USD 1.28B 881.08M 2025-06
Ionis Pharmaceuticals USD 297.3M 33.11M 2025-06
Ligand Pharmaceuticals USD 67.67M 189.22M 2025-06
MacroGenics USD 182.84M 3.22M 2024-12
Merck USD 8.01B 622M 2025-06
Pacira USD 300.48M 16.87M 2025-06
Pfizer USD 1.64B 208M 2025-06
Veracyte USD 219.5M 33.38M 2025-06


Ligand Pharmaceuticals Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.